methotrexate has been researched along with Anaplastic Oligodendroglioma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benko, A; Boudrias, M; Desjardins, A; Fortin, D; Niyonsega, T | 1 |
| Takahashi, H; Tanaka, R | 1 |
| Grant, R; Greenberg, HS; Junck, L; Naylor, B | 1 |
| Hoshino, T; Nagai, M; Sano, K | 1 |
| Mundinger, F | 1 |
| Barker, M; Gordan, GS; Lubich, W; Marton, LJ; Wilson, CB | 1 |
| Luyendijk, W; van Beusekom, GT | 1 |
1 review(s) available for methotrexate and Anaplastic Oligodendroglioma
| Article | Year |
|---|---|
[Chemotherapy for brain tumor].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Drug Delivery Systems; Etoposide; Humans; Lymphoma; Medulloblastoma; Methotrexate; Neoplasms, Germ Cell and Embryonal; Nimustine; Oligodendroglioma; Platinum Compounds; Randomized Controlled Trials as Topic; Vincristine | 2005 |
6 other study(ies) available for methotrexate and Anaplastic Oligodendroglioma
| Article | Year |
|---|---|
Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Child; Disease Progression; Drug Delivery Systems; Female; Glioblastoma; Humans; Infusions, Intra-Arterial; Lymphoma; Male; Methotrexate; Middle Aged; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Survival Rate; Time Factors | 2005 |
Clinical outcome in aggressively treated meningeal gliomatosis.
Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Cerebrospinal Fluid; Combined Modality Therapy; Female; Glioblastoma; Glioma; Humans; Male; Meninges; Methotrexate; Middle Aged; Neuroglia; Oligodendroglioma; Survival Analysis | 1992 |
Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).
Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Culture Techniques; DNA; Floxuridine; Fluorouracil; Follow-Up Studies; Glioma; Humans; Meningioma; Methotrexate; Oligodendroglioma; Radiation-Sensitizing Agents; Thymidine | 1968 |
[Clinical and experimental results of interstitial Curie-therapy combined with radiosensitizing agents in DS carcinoma of the rat and in infiltrating brain neoplasms].
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Carcinosarcoma; Cytidine; Ependymoma; Glioblastoma; Humans; Iridium; Methotrexate; Oligodendroglioma; Radiation-Sensitizing Agents; Rats; Thymidine | 1972 |
Faliure to demonstrate desmosterol in spinal fluid of brain tumor patients.
Topics: Animals; Astrocytoma; Brain Neoplasms; Cholesterol; Chromatography, Gas; Culture Techniques; Desmosterol; Glioblastoma; Glioma; Humans; Methotrexate; Oligodendroglioma; Rats; Sterols; Triparanol | 1973 |
[Chemotherapy of cerebral gliomas. 1st results with intracarotid methotrexate infusions].
Topics: Adult; Astrocytoma; Brain Neoplasms; Female; Humans; Male; Methotrexate; Middle Aged; Oligodendroglioma | 1965 |